Abiomed, Inc.ABMDNASDAQ
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+12.2%
5Y CAGR+15.6%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+12.2%/yr
vs +26.6%/yr prior
5Y CAGR
+15.6%/yr
Recent deceleration
Acceleration
-14.3pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.1x
Strong expansion
Streak
9 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2022 | $586.89M | +28.7% |
| 2021 | $456.06M | +3.6% |
| 2020 | $440.36M | +6.1% |
| 2019 | $415.05M | +22.8% |
| 2018 | $338.03M | +18.8% |
| 2017 | $284.54M | +32.9% |
| 2016 | $214.02M | +32.4% |
| 2015 | $161.70M | +17.2% |
| 2014 | $137.96M | +25.4% |
| 2013 | $109.98M | - |